PaxMedica Inc (NASDAQ:PXMD) saw an upside of 5.07% to close Monday at $0.31 after adding $0.01 on the day. The 5-day average trading volume is 944,600 shares of the company’s common stock. It has gained $0.3359 in the past week and touched a new high 3 times within the past 5 days. An average of 486,100 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 957,702.
PXMD’s 1-month performance is -44.27% or -$0.2240 on its low of $0.2537 reached on 09/15/23. The company’s shares have touched a 52-week low of $0.25 and high of $4.07, with the stock’s rally to the 52-week high happening on 02/03/23. YTD, PXMD has lost -84.68% or -$1.7190 and has reached a new high 12 times. However, the current price is down -92.36% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
PXMD stock investors last saw insider trading activity on Aug 30.Weisman Howard J. (Chairman and CEO) most recently sold 22,535 shares at $0.45 per share on Aug 30. This transaction cost the insider $10,053. Director, Rome Zachary, sold 4,801 shares at a price of $0.47 on Aug 30. Then, on Aug 29, Chairman and CEO Weisman Howard J. sold 9,596 shares at a price of $0.48 per share. This transaction amounted to $4,650.
Valuation Metrics
PXMD stock has a beta of 1.37. Moving on to other valuation ratios, the price-to-book (PB) in the most recent quarter is 2.11.
PaxMedica Inc’s quick ratio for the recent period was 2.12, with the current ratio over the same period at 2.12. The firm’s gross profit as reported stood at $5000.0 against revenue of $10.6 million.
Earnings Surprise
Net income and sales went down compared to those figures reported in the previous quarter. Net income grew 100.29% to -$3.49 million, while revenue of -$3.83 million was -9.74% off the previous quarter. EBITDA for the quarter stood at more than -$3.36 million. PXMD stock balance sheet for the recent quarter shows that total liabilities totaled 2.88 million, with total debt at $1.67 million. Shareholders hold equity totaling $16.44 million.
Let’s look briefly at PaxMedica Inc (PXMD) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 25 September was 34.93% to suggest the stock is trending Neutral, with historical volatility in this time period at 75.97%.
The stock’s 5-day moving average is $0.3013, reflecting a -0.10% or -$0.0003 change from its current price. PXMD is currently trading -41.87% above its 20-day SMA, -77.96% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -61.89% and SMA200 by-86.12%.
Stochastic %K and %D was 22.09% and 19.36% and the average true range (ATR) pointed at 0.0525. The RSI (14) points at 30.05%, while the 14-day stochastic is at 32.84% with the period’s ATR at 0.0564. The stock’s 9-day MACD Oscillator is pointing at -0.0029 and -0.0111 on the 14-day charts.
